HK1174054A1 - Method of screening for agent for improving dry skin associated with atopic dermatitis employing activity of bleomycin hydrolase activity as measure - Google Patents

Method of screening for agent for improving dry skin associated with atopic dermatitis employing activity of bleomycin hydrolase activity as measure

Info

Publication number
HK1174054A1
HK1174054A1 HK13100963.8A HK13100963A HK1174054A1 HK 1174054 A1 HK1174054 A1 HK 1174054A1 HK 13100963 A HK13100963 A HK 13100963A HK 1174054 A1 HK1174054 A1 HK 1174054A1
Authority
HK
Hong Kong
Prior art keywords
activity
screening
measure
agent
atopic dermatitis
Prior art date
Application number
HK13100963.8A
Other languages
English (en)
Chinese (zh)
Inventor
Toshihiko Hibino
Yayoi Kamata
Mami Yamamoto
Original Assignee
Shiseido Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shiseido Co Ltd filed Critical Shiseido Co Ltd
Publication of HK1174054A1 publication Critical patent/HK1174054A1/xx

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/15—Medicinal preparations ; Physical properties thereof, e.g. dissolubility
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6881—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from skin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96466—Cysteine endopeptidases (3.4.22)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/10—Screening for compounds of potential therapeutic value involving cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/20—Dermatological disorders
    • G01N2800/202—Dermatitis

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Plant Pathology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
HK13100963.8A 2009-12-03 2013-01-22 Method of screening for agent for improving dry skin associated with atopic dermatitis employing activity of bleomycin hydrolase activity as measure HK1174054A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2009275909 2009-12-03
PCT/JP2010/071599 WO2011068166A1 (ja) 2009-12-03 2010-12-02 ブレオマオシン水解酵素の活性を指標としたアトピー性皮膚炎による乾燥肌改善剤のスクリーニング方法

Publications (1)

Publication Number Publication Date
HK1174054A1 true HK1174054A1 (en) 2013-05-31

Family

ID=44115012

Family Applications (1)

Application Number Title Priority Date Filing Date
HK13100963.8A HK1174054A1 (en) 2009-12-03 2013-01-22 Method of screening for agent for improving dry skin associated with atopic dermatitis employing activity of bleomycin hydrolase activity as measure

Country Status (9)

Country Link
US (2) US8906629B2 (xx)
EP (1) EP2508605B1 (xx)
JP (1) JP5858788B2 (xx)
KR (1) KR101787126B1 (xx)
CN (1) CN102648278B (xx)
ES (1) ES2541614T3 (xx)
HK (1) HK1174054A1 (xx)
TW (1) TWI528034B (xx)
WO (1) WO2011068166A1 (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5771123B2 (ja) * 2011-11-09 2015-08-26 株式会社 資生堂 プロフィラグリンｃ末端ドメイン特異的抗体及びその用途
JP6199592B2 (ja) * 2013-04-15 2017-09-20 株式会社 資生堂 分析方法
FR3011009B1 (fr) * 2013-09-25 2016-11-25 Oreal Signature bacterienne de la dermatite atopique et son utilisation dans la prevention et/ou le traitement de cette pathologie
JP6462437B2 (ja) * 2014-05-08 2019-01-30 花王株式会社 皮膚の乾燥状態の評価方法
EP4282488A1 (en) * 2021-02-26 2023-11-29 National University Corporation Kobe University Method for evaluating xenobiotic response reaction inducibility of sample of interest in skin, method for searching for substance capable of inhibiting xenobiotic response reaction in skin, and agent capable of inhibiting xenobiotic response reaction in skin
CN113528573A (zh) * 2021-07-29 2021-10-22 徐州医科大学 含有hdac1基因启动子和报告基因的重组质粒及其构建与应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3639002B2 (ja) 1995-06-14 2005-04-13 ヤンマー農機株式会社 普通形コンバインの穀稈刈取装置
US6974667B2 (en) * 2000-06-14 2005-12-13 Gene Logic, Inc. Gene expression profiles in liver cancer
WO2004028339A2 (en) * 2002-09-27 2004-04-08 Brigham And Women's Hospital, Inc. Treatment of patients with multiple sclerosis based on gene expression changes in central nervous system tissues
JP2009521933A (ja) * 2005-12-28 2009-06-11 セントカー・インコーポレーテツド 乾癬および関連障害を評価および処置するためのマーカーおよび方法
JP4803004B2 (ja) 2006-11-28 2011-10-26 旭硝子株式会社 自動車用高周波ガラスアンテナ及び窓ガラス板
FR2920304B1 (fr) 2007-09-04 2010-06-25 Oreal Utilisation cosmetique de lysat bifidobacterium species pour le traitement de la secheresse.
JP5602015B2 (ja) 2008-05-23 2014-10-08 株式会社 資生堂 ブレオマイシン水解酵素の活性を指標とした天然保湿因子による皮膚バリアー機能状態の評価方法

Also Published As

Publication number Publication date
CN102648278A (zh) 2012-08-22
EP2508605A4 (en) 2013-05-01
ES2541614T3 (es) 2015-07-22
EP2508605A1 (en) 2012-10-10
US8906629B2 (en) 2014-12-09
US9068228B2 (en) 2015-06-30
TWI528034B (zh) 2016-04-01
US20150118686A1 (en) 2015-04-30
JPWO2011068166A1 (ja) 2013-04-18
US20120302649A1 (en) 2012-11-29
KR101787126B1 (ko) 2017-10-18
CN102648278B (zh) 2015-03-25
JP5858788B2 (ja) 2016-02-10
WO2011068166A1 (ja) 2011-06-09
EP2508605B1 (en) 2015-05-20
KR20120112445A (ko) 2012-10-11
TW201131169A (en) 2011-09-16

Similar Documents

Publication Publication Date Title
ZA201105933B (en) Methods of diagnosing and treating dysphagia
HK1174054A1 (en) Method of screening for agent for improving dry skin associated with atopic dermatitis employing activity of bleomycin hydrolase activity as measure
ZA201303606B (en) System and method for monitoring operational characteristics of pulverizers
PL2415532T3 (pl) Myjnia części i sposób mycia części
EP2626817A4 (en) METHOD AND SYSTEM FOR MONITORING THE QUALITY OF FOODSTUFFS
EP2416792A4 (en) NEW ANTI-AGING APPROACHES AND METHOD FOR IDENTIFYING THEM
EP2294406A4 (en) Methods and instrumentation for during-synthesis monitoring of polymer functional evolution
EP2416209A4 (en) COVERING DEVICE FOR INSTRUMENT, INSTRUMENT THEREFOR AND METHOD FOR COVERING AN INSTRUMENT TO COVER DISPLAY
EP2552205A4 (en) PROCESS FOR INCREASING SLEEP QUALITY
EP2389573A4 (en) SKIN ANALYSIS PROCEDURE
EP2396777A4 (en) IMPROVED SYSTEM AND METHOD FOR MONITORING HAND WASHING
EP2287465A4 (en) DEVICE AND METHOD FOR MONITORING DYNAMIC PROPERTIES OF A WINDMILL
GB0902018D0 (en) Method for making pentoses and pentose-based oligosaccharides from cereals
EP2517024A4 (en) ANALYSIS METHOD WITH ENHANCED MIXING
HRP20160965T1 (hr) Instant suhi rezanci i postupak za njihovu proizvodnju
EP2446048A4 (en) MEASURING METHODS AND KITS FOR ENZYMATIC ACTIVITY
GB2509274B (en) Method and arrangement for evaluating activity and functional ability based on interaction and physiological signals
EP2896694A4 (en) GLUCIDE OXIDASE AND METHOD FOR PRODUCTION AND USE
EP2444814A4 (en) BIOMARKERS FOR PSYCHICAL ILLNESSES INCLUDING COGNITIVE DISORDER AND METHODS USING SUCH BIOMARKERS FOR DETECTING PSYCHICAL ILLNESSES INCLUDING COGNITIVE INTERFERENCE
HK1174391A1 (en) Method of examining atopic dermatitis
EP2504931A4 (en) ARRANGEMENT AND METHOD FOR ANALYZING TRANSMISSION LINES
HUE039597T2 (hu) Eljárás galaktozémia kimutatására újszülöttek szûrésekor
HRP20131121T1 (hr) Postupak za poboljšanje neprozirnosti
EP2501171A4 (en) METHOD AND SYSTEM FOR MEASURING MACHINE BACKGROUND NOISE
PL2575768T3 (pl) Wodna dyspersja zawierająca galaktolipidy oraz sposób jej wytwarzania

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20201202